肺癌射频消融幻灯片.pptVIP

背景 22.7%的肺癌死亡率占恶性肿瘤首位； 80％的患者确诊时已丧失了手术根治的机会； 80％为NSCLC，单纯放化疗效果并不理想； 肿瘤治疗强调多学科综合治疗，延缓病情，提高生存质量； RFA微创治疗方法正在成为当今的研究热点。 专家评述早期临床研究对射频消融（RFA）的可行性、安全性、耐受性和局部效果进行了评价，其破坏肿瘤的有效性和可重复性已被证实，且并发症和死亡率较低。近年来，射频治疗方法显著改善，成为显著发展的热点技术。C. StroszczynskiThe early clinical studies of RFA were performed in order to assess feasibility aiming at safety, tolerability, and local therapeutic effect of the treatment. The effective and reproducible tumor destruction comes along with an acceptable mortality and morbidity. During recent years, RFA has evolved significantly concerning technical developments and procedure-rela